Status:
COMPLETED
Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
Lead Sponsor:
Fisher and Paykel Healthcare
Conditions:
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nasal Continuous Positive Airway Pressure (CPAP) is the standard therapy for obstructive sleep apnea hypopnea syndrome (OSAHS). This is most commonly administered as a single positive pressure that ha...
Eligibility Criteria
Inclusion
- AHI \>15 on the diagnostic portion of the study
- \>18 years of age
Exclusion
- Significant Central Apnea
- Congestive Heart Failure
- Inability to give informed consent
- Patient intolerance to CPAP
- Anatomical or physiological conditions making CPAP therapy inappropriate
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00750165
Start Date
May 1 2007
End Date
January 1 2008
Last Update
April 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Sleep Disorders Center
New York, New York, United States, 10016